[1] Gao H, Liu YD, Wang RB, Wang Q, Jin LY, Wang H. The transferability and evolution of NDM-1 and KPC-2 co-producing Klebsiella pneumoniae from clinical settings. EBioMedicine 2020;51:102599.
[2] Popowska M, Krawczyk-Balska A. Broad-host-range IncP-1 plasmids and their resistance potential. Front Microbiol 2013;4:44.
[3] Gomez-Simmonds A, Greenman M, Sullivan SB, Tanner JP, Sowash MG, Whittier S, et al. Population structure of Klebsiella pneumoniae causing bloodstream infections at a New York City tertiary care hospital: diversification of multidrug-resistant isolates. J Clin Microbiol 2015;53(7):20607.
[4] Wang XL, Tang B, Liu GT, Wang M, Sun JY, Tan RM, et al. Transmission of nonconjugative virulence or resistance plasmids mediated by a self-transferable IncN3 plasmid from carbapenem-resistant Klebsiella pneumoniae. Microbiol Spectr 2022;10(4):e0136422.
[5] Ghiglione B, Haim MS, Penzotti P, Brunetti F, D´Amico González G, Di Conza J, et al. Characterization of emerging pathogens carrying blaKPC-2 gene in IncP-6 plasmids isolated from urban sewage in Argentina. Front Cell Infect Microbiol 2021;11:722536.
[6] Lo WU, Cheung YY, Lai E, Lung D, Que TL, Ho PL. Complete sequence of an IncN plasmid, pIMP-HZ1, carrying blaIMP-4 in a Klebsiella pneumoniae strain associated with medical travel to China. Antimicrob Agents Chemother 2013;57(3):15612.
[7] Zhang XF, Wang LL, Li D, Li P, Yuan LL, Yang F, et al. An IncP-2 plasmid sublineage associated with dissemination of blaIMP-45 among carbapenem-resistant Pseudomonas aeruginosa. Emerg Microbes Infect 2021;10(1):4429.
[8] Ota Y, Prah I, Nukui Y, Koike R, Saito R. blaKPC-2-encoding IncP-6 plasmids in Citrobacter freundii and Klebsiella variicola strains from hospital sewage in Japan. Appl Environ Microbiol 2022;88(8):e0001922.
[9] Fang L, Shen YH, Chen RY, Li CY, Liu RS, Jia YY, et al. The characterization of an IncN-IncR fusion plasmid co-harboring blaTEM−40, blaKPC−2, and blaIMP−4 derived from ST1393 Klebsiella pneumoniae. Sci Rep 2024;14(1):26723.
[10] Mayorga-Ramos A, Zúñiga-Miranda J, Carrera-Pacheco SE, Barba-Ostria C, Guamán LP. CRISPR-Cas-based antimicrobials: design, challenges, and bacterial mechanisms of resistance. ACS Infect Dis 2023;9(7):1283302.